Steps Through OC Awarded the 2019 AONN+ Outstanding Poster Award for Exceptional Research in Navigation

November 7, 2019 5:00 pm

Photo: Marina Baroff, MPH, FACHE, Senior Director, Service Innovation
mbaroff@stepsthrough.org | www.stepsthrough.org

The Clearity Foundation is proud to announce that our new support program, Steps Through OC, has been selected for the 2019 AONN+ Outstanding Poster Award for Exceptional Read more

An Introduction to Ovarian Cancer Awareness Month 2019

September 1, 2019 8:00 am

By Dr. Laura Shawver, Founder of The Clearity Foundation

Whenever I talk with someone who just received an ovarian cancer diagnosis, it brings back the feelings that I had when I heard the words, “you have ovarian cancer.” I can … Read more

Clearity’s Scientific Director, Dr. Deb Zajchowski, Presents Poster at SGO: Genomic Mutation Profiles of Paired Ovarian Cancers Across Time

March 16, 2019 9:00 am

Clearity’s Scientific Director, Dr. Deb Zajchowski, presented a poster at the SGO’s 50th Annual Meeting on Women’s Cancers entitled: Genomic Mutation Profiles of Paired Ovarian Cancers Across Time.

The data presented describes some of the research being done utilizing The … Read more

SXSW Panel: ‘Frontiers of Cancer: Racing Toward A Cure’

March 9, 2019 6:00 pm

Clearity’s Executive Director, Hillary Theakston, spoke on a panel of industry leaders at SXSW on ‘Frontiers of Cancer: Racing Toward A Cure’. Hillary, along with fellow panelists Amy Puliafito, Bobbie Rimel, MD, and Karl Handelsman discussed major investments, … Read more

Will You Give On #GivingTuesday?

November 26, 2018 3:48 am

The Clearity Foundation has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide.

Celebrated on the Tuesday following Thanksgiving, and the widely recognized shopping … Read more

Clearity’s Teal Woman 10th Anniversary Celebration

October 10, 2018 4:21 pm

The Clearity Foundation held its Teal Woman 10th Anniversary Celebration on September 16, 2018, at the Paradise Point Resort. The event, themed, “Teal Woman: Celebrating Life. Honoring Courage. Recognizing Progress. Changing the Story for Ovarian Cancer,” helped us to shine … Read more

An Introduction To Ovarian Cancer Awareness Month 2018

August 31, 2018 6:25 pm

By: Dr. Laura Shawver, Founder of The Clearity Foundation

Whenever I talk with someone that just received an ovarian cancer diagnosis, it brings back the feelings that I had when I heard the words, “you have ovarian cancer.” I can … Read more

Clearity Presents Results at ASCO Conference

June 13, 2018 7:22 pm

Results from analysis of clinical and tumor profiling data from ovarian cancer patients in the Clearity Foundation Data Repository were presented in two studies at the recent ASCO conference that took place June 1-5 in Chicago, Ill.

The first study

Read more

Clinical Trials Offer Promising New Treatments for Ovarian Cancer

February 5, 2018 9:10 pm

By: Deborah Zajchowski, PhD – Scientific Director, The Clearity Foundation

In the past three years, new hope has come to many women with ovarian cancer because of four new drugs that were approved for the treatment of this disease. These … Read more

An Introduction To Ovarian Cancer Awareness Month

September 1, 2017 4:30 am

By: Dr. Laura Shawver, Founder of The Clearity Foundation

Ten years ago, I was recovering from chemotherapy following my ovarian cancer diagnosis. As a scientist and a cancer drug developer, I knew the odds. I also knew that progress in … Read more

Ovarian Cancer Clinical Trial Results: Data Points to Treatment Options Beyond Standard Chemotherapy

February 1, 2017 5:19 pm

By: Cory Bentley, PhD

Many women diagnosed with ovarian cancer could probably write a dissertation for an advanced degree on ovarian cancer. Whether women are newly diagnosed or have recurrent ovarian cancer, the new learning needed to make informed decisions

Read more

Profile-Matched Patient Assistance and Clinical Trial Options

May 2, 2016 8:38 pm

Clearity has taken steps to help accelerate molecular matching by enabling women to access the drugs their physicians prescribe to treat their ovarian cancer. The pilot Clearity Match Patient Assistance program that was recently announced helps subsidize the cost of … Read more

Clearity’s Precision Medicine Symposium Demonstrates Sea Change in Personalized Ovarian Cancer Treatment

May 2, 2016 8:38 pm

By: Cory Bentley, PhD

The Society for Gynecological Oncology (SGO) Meeting this March in San Diego brought together physicians and scientists from all over the world to share the latest research, treatments, and thinking in gynecological cancers including ovarian. Clearity … Read more

2016 Program Project Development Award Recipient

January 6, 2016 9:22 pm

The Clearity Foundation is proud to announce that our Scientific Advisory Board (SAB) Chair, Dr. Beth Karlan of Cedars-Sinai Medical Center, is the recipient of the 2016 Program Project Development Award. She submitted her work on the ‘Co-Evolution of Read more

Molecular Profiling As a Necessity for Uncommon Ovarian Cancers

November 5, 2015 11:00 am

By: Laura Shawver

In 1998, Herceptin was approved for women with breast cancer whose tumors have extra copies of the Her2/ERBB2 gene and since that time, there have been more than 25 drugs approved to treat cancers with specific genetic … Read more

Liz Laats Shares Her Story at Clearity’s Glitter and Glue for Good

October 27, 2015 11:00 am

Check out Liz Laats’ amazing speech at Glitter and Glue for Good, not a dry eye in the house.

Thank you to everyone who joined us on March 7th for the inaugaural Glitter & Glue for Good event. More than … Read more

Novel Clinical Trial Designs Match Drugs to Patient’s Tumor Profiles

September 1, 2014 8:07 pm

By: Cory Bentley, PhD

Bringing new treatments to ovarian cancer patients is very challenging.  There are not as many patients diagnosed with this cancer as there are with other cancer types, such as breast, lung and colorectal, so there are … Read more

Eligibility Criteria in Clinical Trials: PARP Inhibitors

July 1, 2013 7:59 pm

By: Cory Bentley, PhD

Clearity first reported on drugs inhibiting PARP (Poly-ADP ribose polymerase), an important enzyme for tumor cell proliferation and survival, in its September 2010 patient newsletter.  At that time, PARP inhibitors were just entering clinical trials and

Read more